Westfield Capital Management CO LP Eli Lilly & CO Transaction History

Westfield Capital Management CO LP

$21.6 Billion
Q4 2024

A detailed history of Westfield Capital Management CO LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Westfield Capital Management CO LP holds 219,993 shares of LLY stock, worth $188 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

219,993

Previous 26,351 734.86%

Holding current value

$188 Million

Previous $23.3 Million 627.5%

% of portfolio

0.79%

Previous 0.11%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$727.2 - $932.06 $141 Million - $180 Million	193,642 Added 734.86%	219,993 $170 Million
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $2.67 Million - $3.31 Million	-3,452 Reduced 11.58%	26,351 $23.3 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.07 Million - $1.34 Million	1,478 Added 5.22%	29,803 $27 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $82.9 Million - $111 Million	-140,005 Reduced 83.17%	28,325 $22 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $61.8 Million - $72.9 Million	-117,685 Reduced 41.15%	168,330 $98.1 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $48.2 Million - $66.5 Million	-110,935 Reduced 27.95%	286,015 $154 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $3.29 Million - $4.4 Million	9,386 Added 2.42%	396,950 $186 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $18.5 Million - $21.7 Million	59,440 Added 18.12%	387,564 $133 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $10.8 Million - $12.6 Million	-33,616 Reduced 9.29%	328,124 $120 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $107 Million - $122 Million	361,040 Added 51577.14%	361,740 $117 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $195,111 - $229,089	700 New	700 $227,000
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $8.26 Million - $9.48 Million	-109,170 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $68.5 Million - $80.9 Million	-923,681 Reduced 89.43%	109,170 $8.45 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $30.6 Million - $32.8 Million	-373,662 Reduced 26.57%	1,032,851 $87.2 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $108 Million - $120 Million	1,406,513	1,406,513 $120 Million

Others Institutions Holding LLY

# of Institutions

4,291

Shares Held

744M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $810B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account

Westfield Capital Management CO LP Eli Lilly & CO Transaction History